Meena Madhur
@cvimmunology.bsky.social
Cardiovascular physician-scientist, mom, wife, mentor and mentee for life. I believe in science. Fascinated by the immune system. Posts are my own.
Hi. Please add me.
November 20, 2024 at 6:10 PM
Hi. Please add me.
Please add me and @amandadoranlab.bsky.social
November 18, 2024 at 3:03 PM
Please add me and @amandadoranlab.bsky.social
Can you add me?
November 17, 2024 at 12:12 AM
Can you add me?
Reposted by Meena Madhur
The 2024 ESC guideline says all-comers with HTN. It’s been shown to be cost-effective across all-comers. I think Greg Hundemer’s work on the target organ effects of subclinical primary aldo is compelling 👇. I’ve been checking anyone with uncontrolled HTN
www.ahajournals.org/doi/10.1161/...
www.ahajournals.org/doi/10.1161/...
Subclinical Primary Aldosteronism and Cardiovascular Health: A Population-Based Cohort Study | Circulation
BACKGROUND: Primary aldosteronism, characterized by overt renin-independent aldosterone production,
is a common but underrecognized form of hypertension and cardiovascular disease. Growing
evidence su...
www.ahajournals.org
November 13, 2024 at 1:02 AM
The 2024 ESC guideline says all-comers with HTN. It’s been shown to be cost-effective across all-comers. I think Greg Hundemer’s work on the target organ effects of subclinical primary aldo is compelling 👇. I’ve been checking anyone with uncontrolled HTN
www.ahajournals.org/doi/10.1161/...
www.ahajournals.org/doi/10.1161/...